Epidemiology of colorectal cancer in the Republic of Kazakhstan

2021

Closed access Metadata (CSL-JSON)
DOI 10.52532/2521-6414-2021-3-61-9-14
Data confidence 70 medium
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

Relevance: Today, colorectal cancer is one of the most important health issues in Kazakhstan and worldwide. Colorectal cancer leading positions in the general structure of oncopathologies force clinicians to develop ways to improve its statistical indicators. The purpose of the study was to investigate the epidemiological aspects of colorectal cancer in the Republic of Kazakhstan in 2010-2019. Results: The article presents and analyzes the epidemiological indicators of colorectal cancer in the Republic of Kazakhstan over the past decade. The incidence trends were studied considering the territorial characteristics, early detection, and neglect indicators for this type of malignant neoplasms in this country. We also analyzed the 5-year survival, one-year fatality, and mortality rates for the studied period. Comprehensive comparative analysis of these epidemiological indicators made it possible to visualize the results of many years of work to improve oncological indicators and formulate further improvement directions. Conclusions: An analytical assessment of colorectal cancer statistical indicators of over a decade showed an increase in incidence, with some regions leading year to year. However, such indicators as early detection, one-year fatality, and mortality from colorectal cancer have improved.